Ellanse M – Advanced Biostimulatory Volumizer

Ellanse M represents a paradigm shift in aesthetic medicine, moving beyond temporary hydration toward long-term structural regeneration. Unlike traditional hyaluronic acid fillers that are metabolized in months, Ellanse M is composed of Polycaprolactone (PCL) microspheres suspended in a Carboxymethylcellulose (CMC) gel carrier. It is the premier choice for clinicians seeking a biostimulatory effect that provides stability and natural-looking results for up to 24 months.

Dual-Phase Action: Immediate Lift and Neocollagenesis

The performance of Ellanse M is divided into two critical phases:

• Phase 1 (Immediate Lift): The CMC gel carrier fills wrinkles and restores lost volume instantly upon injection, providing a precise mechanical lift.

• Phase 2 (Neocollagenesis): As the CMC gel is gradually absorbed, the PCL microspheres remain in the tissue, acting as a powerful stimulus for the production of Type I collagen. This endogenous collagen replaces the gel carrier, ensuring the volumization remains stable and natural-looking throughout the entire duration of the treatment.

Safety, Biocompatibility, and Clinical Applications

Polycaprolactone is a well-established bio-resorbable medical polymer used in surgical applications for decades. Ellanse M leverages this safety profile to provide a predictable, controlled degradation process (Tunable Longevity). It is exceptionally effective for contouring the mid-face, defining the jawline, and projecting the chin. Because it stimulates the skin’s own density, it improves overall skin texture and elasticity, acting as a comprehensive skin quality treatment.

Professional Protocol

Ellanse M is a Class III implantable medical device and must be used exclusively by qualified healthcare professionals.

• Injection: The product should be injected into the deep dermis or sub-dermal layers.

• Technique: Practitioners should use a 27G needle and employ a tunneling or fan technique for even distribution.

• Note: It is crucial to avoid over-correction, as the secondary collagen production will further enhance the initial volume. For full details on indications, contraindications, and posology, please refer to the Instruction for Use (IFU) provided by the manufacturer.

General Information

Developed by Sinclair Pharma, the Ellanse M range marks a significant advancement in medical aesthetics. Designed specifically to treat facial volume loss, this product is the ideal solution for patients seeking durable, effective results. It is highly effective for treating areas prone to aging, such as cheeks, temples, and nasolabial folds, and is highly regarded by both medical practitioners and patients.

Composition and Ingredients

The following table outlines the formulation and key components of Ellanse M:

Allergy Advisory: This product is composed of fully resorbable components. While allergies are rare, it is recommended to consult with a health professional prior to injection, particularly for patients with a history of sensitivity to similar dermal products.

Key Benefits

• Long-Lasting Results: Restores facial volume for 1 to 2 years, offering superior longevity compared to many standard fillers.

• Immediate Effect & Prolonged Stimulation: The combination of CMC and PCL provides instant volumization followed by sustained collagen synthesis for a natural, youthful appearance.

• Targeted Treatment: Ideal for deep wrinkles, skin laxity, and facial contouring, leaving the skin revitalized and lifted.

How long do the effects of Ellanse M last?

The results of Ellanse M can last between 1 and 2 years. The exact duration depends on individual patient factors, including age, skin quality, metabolic rate, and lifestyle.

Is Ellanse M suitable for all patients?

Ellanse M is intended for use by qualified medical professionals only. Patients should undergo a thorough clinical consultation to discuss their medical history and aesthetic goals to determine if this biostimulatory treatment is the appropriate solution for their specific needs.

What makes Ellanse M different from hyaluronic acid fillers?

While standard HA fillers provide volume primarily through hydration and are absorbed relatively quickly by the body, Ellanse M provides an immediate mechanical lift followed by a long-term biostimulatory process. This triggers the patient’s own natural collagen production, resulting in structural, long-term tissue regeneration rather than a simple filler effect.

LEGAL NOTICE: Independent distributor. Original Sinclair product used for identification purposes only.